Status:

COMPLETED

Ultra-wide Diameter Implants in Mandibular Molars

Lead Sponsor:

Abdelrahman Elshahawy

Conditions:

Dental Implants

Eligibility:

All Genders

20-40 years

Phase:

NA

Brief Summary

The goal of this \[clinical trial\] is to \[To evaluate both the clinical and radiographical outcome on osteointegration and peri-implant bone density when using ultra wide diameter implant placed imm...

Detailed Description

the aim of this study is to evaluate the clinical and radiographical outcomes on osseointegration and peri-implant bone density when using 12 ultrawide diameter dental implants placed immediately in 1...

Eligibility Criteria

Inclusion

  • Adult patients ranging from 20-40 years.
  • Adequate bone beyond teeth apices without jeopardizing any anatomical structure.
  • Non-restorable mandibular molar teeth.
  • Available bone with adequate width and buccolingual dimensions.
  • Peri-implant bone defect should be 2mm or lesser.

Exclusion

  • Smokers.
  • Medically compromised patients like uncontrolled diabetes and coagulation disorders.
  • Tooth with periapical pathosis or bony defects.

Key Trial Info

Start Date :

May 20 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 3 2022

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT05972447

Start Date

May 20 2021

End Date

March 3 2022

Last Update

August 2 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Alexandria University

Alexandria, Egypt, 20200